We are live on ! Find out more
PP

Paloma Partners Portfolio holdings

AUM $510M
1-Year Est. Return 286.05%
This Fund
S&P 500
This Quarter Est. Return
+5.02%
1 Year Est. Return
+286.05%
3 Year Est. Return
+321.92%
5 Year Est. Return
+284.54%
10 Year Est. Return
+855.7%
AUM
$3.78B
AUM Growth
-$541M
Cap. Flow
-$699M
Cap. Flow %
-18.5%
Top 10 Hldgs %
26.03%
Holding
2,134
New
570
Increased
494
Reduced
496
Closed
467

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$28.7M
2
FXE icon
Invesco CurrencyShares Euro Currency Trust
FXE
+$23.2M
3
BIIB icon
Biogen
BIIB
+$20.8M
4
NKE icon
Nike
NKE
+$18.3M
5
IBM icon
IBM
IBM
+$17.2M

Sector Composition

Rank Sector Weight
1 Healthcare 6.62%
2 Industrials 6.54%
3 Financials 6.19%
4 Technology 6.15%
5 Consumer Discretionary 5.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FL
826
DELISTED
Foot Locker
FL
$713K 0.02%
+10,966
New +$729K
HIG icon
827
CALL
Hartford Financial Services
HIG
$39.7B
$713K 0.02%
16,400
-13,600
-45% -$624K
HIG icon
828
PUT
Hartford Financial Services
HIG
$39.7B
$713K 0.02%
16,400
-13,600
-45% -$624K
TSM icon
829
TSMC
TSM
$1.96T
$710K 0.02%
31,224
-10,832
-26% -$244K
RDN icon
830
Radian Group
RDN
$5.3B
$708K 0.02%
+52,881
New +$775K
BBWI icon
831
Bath & Body Works
BBWI
$3.98B
$705K 0.02%
9,104
-32,835
-78% -$2.54M
DCH
832
Dauch Corp
DCH
$1.31B
$704K 0.02%
37,211
+19,706
+113% +$415K
DBI icon
833
Designer Brands
DBI
$310M
$704K 0.02%
29,498
-10,518
-26% -$253K
NUS icon
834
Nu Skin
NUS
$253M
$704K 0.02%
18,612
-1,936
-9% -$71.3K
ZION icon
835
Zions Bancorporation
ZION
$10.2B
$704K 0.02%
+25,810
New +$741K
PM icon
836
PUT
Philip Morris
PM
$313B
$703K 0.02%
8,000
-4,000
-33% -$347K
RSX
837
DELISTED
VanEck Russia ETF
RSX
$703K 0.02%
+48,000
New +$785K
HAR
838
DELISTED
Harman International Industries
HAR
$700K 0.02%
7,430
+4,100
+123% +$416K
SWKS icon
839
Skyworks Solutions
SWKS
$9.52B
$698K 0.02%
+9,088
New +$728K
PAYX icon
840
Paychex
PAYX
$44B
$697K 0.02%
+13,165
New +$688K
PMT
841
PennyMac Mortgage Investment
PMT
$850M
$696K 0.02%
45,593
+33,979
+293% +$529K
ISRG icon
842
Intuitive Surgical
ISRG
$127B
$695K 0.02%
11,439
-58,851
-84% -$3.31M
SIRI icon
843
SiriusXM
SIRI
$10.7B
$694K 0.02%
17,049
+3,879
+29% +$157K
DLX icon
844
Deluxe
DLX
$1.26B
$693K 0.02%
12,694
+1,122
+10% +$64.8K
FNV icon
845
Franco-Nevada
FNV
$40.4B
$693K 0.02%
+15,154
New +$734K
HSIC icon
846
Henry Schein
HSIC
$9.8B
$693K 0.02%
+11,182
New +$665K
FRC
847
DELISTED
First Republic Bank
FRC
$692K 0.02%
+10,483
New +$693K
ASB icon
848
Associated Banc-Corp
ASB
$5.83B
$688K 0.02%
36,690
+2,509
+7% +$48.7K
SCI icon
849
Service Corp International
SCI
$11.6B
$688K 0.02%
26,438
-16,061
-38% -$439K
ON icon
850
ON Semiconductor
ON
$31.6B
$687K 0.02%
70,144
+35,398
+102% +$372K

Similar funds

Paloma Partners's Q4 2015 Portfolio in Review

As of Q4 2015, Paloma Partners held 2,134 positions worth $3.78B, down 13% from $4.32B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Paloma Partners withdrew a net $699M in Q4 2015, closing 467 positions and reducing 496 holdings. Its most notable exit was SIGMA - ALDRICH CORP, an estimated $48.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 6.6% of assets, up from 5.8% a quarter earlier, followed by Industrials and Financials.

Against the trend, Paloma Partners opened a new position in Allergan plc worth $30.1M.

  • Paloma Partners's largest Q4 2015 buy was Allergan plc: 96,344 shares worth $30.1M.
  • Paloma Partners added most to Biogen in Q4 2015, an estimated $20.8M increase.
  • Paloma Partners's biggest Q4 2015 reduction was Regeneron Pharmaceuticals, cutting an estimated $46.2M.
  • Paloma Partners fully exited SIGMA - ALDRICH CORP in Q4 2015, selling an estimated $48.6M.
  • Paloma Partners's ten largest holdings make up 26% of its $3.78B portfolio in Q4 2015.
  • Paloma Partners opened 570 new positions and closed 467 in Q4 2015.
  • Paloma Partners's portfolio value fell 13% quarter-over-quarter to $3.78B.

Based on Paloma Partners's 13F filing for Q4 2015, filed 16 Feb 2016.